GLOBAL ANTIFUNGAL AGENTS(DRUGS, THERAPIES AND APPLICATIONS) MARKET FORECAST 2017-2025

  • You are here:
  • Home
  • Reports
  • GLOBAL ANTIFUNGAL AGENTS(DRUGS, THERAPIES AND APPLICATIONS) MARKET FORECAST 2017-2025

GLOBAL ANTIFUNGAL AGENTS(DRUGS, THERAPIES AND APPLICATIONS) MARKET FORECAST 2017-2025

The global antifungal drugs market is expected to grow from $ 12567 million in 2016 to $17428 million by 2025, at a CAGR of 3.70% between 2017 and 2025. The base year considered for the market study is 2016 and the forecast period is between 2017 and 2025. The antifungal drugs market is witnessing high growth shortly due to increasing awareness among people about various fungal infections etc. which is helping to boost the antifungal drugs market.

GLOBAL ANTIFUNGAL AGENTS(DRUGS, THERAPIES & APPLICATIONS) MARKET FORECAST 2017-2025

Global Antifungal Agents (Drugs, Therapies, & Applications) Market by Drug Types (Echinocandins, Azoles, Polyenes, Allylamines & Others) by Therapeutic Indications (Aspergillosis, Dermatophytosis, Candidiasis, Others) by Applications (Topical Antifungal Drugs, Oral Drugs) by Geography

Request free sample

The global antifungal drugs market is expected to grow from $ 12567 million in 2016 to $17428 million by 2025, at a CAGR of 3.70% between 2017 and 2025. The base year considered for the market study is 2016 and the forecast period is between 2017 and 2025. The antifungal drugs market is witnessing high growth shortly due to increasing awareness among people about various fungal infections etc. which is helping to boost the antifungal drugs market.

The topical drugs application is expected to dominate the global antifungal drugs market. Topical drugs are those medications which are directly applied to the skin or the affected portion of the body. These come in wide forms like pastes, ointments, powder, and others. Most of the topical drugs have systematic effects because they are first absorbed by the skin and are then circulated. Proper handling of the topical drug is a major concern because mishandling of the drug can lead to complications. The oral drugs are anticipated to grow at a faster rate during the forecast period. The Oral antifungal drugs include fluconazole, terbinafine, itraconazole, and ketoconazole. These oral antifungal drugs are reserved for serious infection for which topical antifungal drugs are ineffective or inappropriate. Most of the oral antifungal drugs are the medicines which are available only through prescription and are available in dosage forms such as capsules, suspensions, and tablets.

Antifungal Agents Market

On the basis of the drug types, azoles hold the largest market share in 2016 and echinocandins is anticipated to grow at a cagr of 9.39% during the forecast period. Echinocandins are characterized by their capability to prevent synthesis of a key component of the fungal cell wall. Azole antifungals are characterized by the capability to prevent ergosterol synthesis in fungal membranes. The aspergillosis therapeutic indications market holds the largest market share in 2016 and will eventually continue to be the largest market domain in 2025. Aspergillosis refers to an infection that is caused by Aspergillus (a type of fungus). Such kind of fungus is often found in stored grain, dead leaves, and compost piles or in other decaying vegetation. It can also be present on marijuana leaves. The candidiasis market is anticipated to grow at a faster rate. Candidiasis refers to a fungal infection, a type of yeast (candida). There are around twenty species of candida yeasts that can cause infections in human beings, amongst which the most common is candida albicans. Normally, candida yeasts exist on the skin and mucous membranes without causing infection. Thus, the overgrowth of these organisms can develop symptoms.

Global antifungal drugs market in North America holds the largest market share in 2016 owing to its rising incidence of fungal infections and the development of novel antifungal biopharmaceuticals etc. The major reason for the burgeoning growth in this region is the huge investments made in drug productions along with the government initiatives related to fungal infections and their treatment. Its healthcare investment drives the growth of the antifungal drugs market in the United States. However, Asia-Pacific would be the fastest growing region for the global antifungal drugs market. The major reason behind the success of this region is rising geriatric population along with the rising awareness amongst people towards healthcare and personal care in the developing countries like China, India, etc. Whereas, stringent regulatory approvals are hindering the growth of the market in Asia Pacific region. Europe’s market is anticipated to grow in the forecast year due to tremendous advantages of diversity.

Poor hygiene habits, development of drug resistance, healthcare policies and programs by the government are the major drivers for the antifungal drugs market. The antifungal drugs market is continuously growing owing to the rising number of patients suffering from the hygiene related diseases majorly in the developing countries and also some of the developed countries. Conversely, factors inhibiting the market growth are alternate treatment options, regulatory atmosphere. The various market opportunities available in the market include healthcare and related industries growing continuously, increasing awareness and availability of information. The growth in the healthcare industry from last few years supported by the government have created significant growth opportunities for the antifungal drugs market. The Side effects and recurring fungal infections, resistance to drugs, rapidly changing technology are the major challenges faced by the antifungal drugs market.

Major players for the Antifungal drugs market are Abbott Laboratories, Arbor Pharmaceuticals Inc., 3 Baxter, Astellas Pharma Inc., Bayer Healthcare, Teva Pharmaceuticals, Gilead, GlaxoSmithKline, Johnson & Johnson, Kramer Laboratories, Merck & co., Novartis, Pfizer, Sanofi-Aventis, vertex pharmaceuticals. Major companies involved in this market are Astellas Pharma Inc., Johnson & Johnson, Teva Pharma, Novartis, and Pfizer. Among all these companies, Astellas Pharma is the biggest in terms of production and market capitalization. The global market is growing because of the high demand of anti-fungal products. Companies are trying to capture more market share through various strategic initiatives.

  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
    • ESTIMATION METHODOLOGY
  3. EXECUTIVE SUMMARY
    • MARKET DEFINITION AND SCOPE
    • KEY FINDINGS
      • TROPICAL DRUGS MARKET IS THE EMERGING APPLICATION
      • ASPERGILLOSIS THERAPEUTIC INDICATION IS LEADING THE MARKET
      • ECHINOCANDINS MARKET HOLDS THE LARGEST MARKET SHARE IN TERMS OF DRUGS TYPE
  1. MARKET DYNAMICS
    • DRIVERS
      • POOR HYGIENE HABITS
      • DEVELOPMENT OF DRUG RESISTANCE
      • HEALTHCARE POLICIES AND PROGRAMS BY GOVERNMENT
    • RESTRAINTS
      • ALTERNATE TREATMENT OPTIONS
      • REGULATORY ATMOSPHERE
    • OPPORTUNITIES
      • HEALTHCARE AND RELATED INDUSTRIES ARE GROWING CONTINUOUSLY
      • INCREASING AWARENESS AND AVAILABILITY OF INFORMATION
    • CHALLENGES
      • SIDE EFFECTS AND RECURRING FUNGAL INFECTIONS
      • RESISTANCE TO DRUGS
      • RAPIDLY CHANGING TECHNOLOGY
  1. MARKET SEGMENTATION
    • BY DRUG TYPES
      • ECHINOCANDINS MARKET
      • AZOLES MARKET
      • POLYENES MARKET
      • ALLYLAMINES MARKET
      • OTHERS MARKET
    • BY THERAPEUTIC INDICATIONS
      • ASPERGILLOSIS MARKET
      • DERMATOPHYTOSIS MARKET
      • CANDIDIASIS MARKET
      • OTHERS MARKET
    • BY APPLICATIONS
      • TOPICAL ANTIFUNGAL AGENTS MARKET
      • ORAL DRUGS MARKET
  1. KEY ANALYTICS
    • PORTER’S FIVE FORCE MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
      • BARGAINING POWER OF BUYER
      • BARGAINING POWER OF SUPPLIER
      • INTENSITY OF COMPETITIVE RIVALRY
    • PESTEL ANALYSIS
    • KEY BUYING CRITERIA
    • VALUE CHAIN ANALYSIS
    • STRATEGIC RECOMMENDATION
    • STRATEGIC CONCLUSIONS
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
  2. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA ANTIFUNGAL AGENTS MARKET 2017-2025 ($ MILLION)
      • UNITED STATES (U.S.) ANTIFUNGAL AGENTS MARKET
      • CANADA ANTIFUNGAL AGENTS MARKET
    • EUROPE ANTIFUNGAL AGENTS MARKET
      • UNITED KINGDOM (UK) ANTIFUNGAL AGENTS MARKET
      • FRANCE ANTIFUNGAL AGENTS MARKET
      • GERMANY ANTIFUNGAL AGENTS MARKET
      • SPAIN ANTIFUNGAL AGENTS MARKET
      • ITALY ANTIFUNGAL AGENTS MARKET
      • ROE ANTIFUNGAL AGENTS MARKET
    • ASIA PACIFIC ANTIFUNGAL AGENTS MARKET
      • INDIA ANTIFUNGAL AGENTS MARKET
      • CHINA ANTIFUNGAL AGENTS MARKET
      • JAPAN ANTIFUNGAL AGENTS MARKET
      • ROAPAC ANTIFUNGAL AGENTS MARKET
    • REST OF THE WORLD ANTIFUNGAL AGENTS MARKET
      • LATIN AMERICA ANTIFUNGAL AGENTS MARKET
      • MENA ANTIFUNGAL AGENTS MARKET
      • AFRICA ANTIFUNGAL AGENTS MARKET
  1. COMPETITIVE LANDSCAPE
    • MARKET SHARE ANALYSIS
    • TOP WINNING STRATEGIES
  2. COMPANY PROFILES
    • ABBOTT LABORATORIES.
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • ARBOR PHARMACEUTICALS, INC.
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • 3 BAXTER
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • ASTELLAS PHARMA INC.
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • BAYER HEALTHCARE
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVE
    • TEVA PHARMACEUTICALS
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • GILEAD
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • GLAXOSMITHKLINE
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC MOVES
    • JOHNSON & JOHNSON
      • OVERVIEW
      • PRODUCTS
      • SCOT ANALYSIS
      • STRATEGIC MOVES
    • KRAMER LABORATORIES
      • OVERVIEW
      • PRODUCTS
      • SCOT ANALYSIS
    • MERCK & CO.
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC MOVES
    • NOVARTIS
      • OVERVIEW
      • PRODUCTS
      • SCOT ANALYSIS
      • STRATEGIC MOVES
    • PFIZER
      • OVERVIEW
      • PRODUCTS
      • SCOT ANALYSIS
      • STRATEGIC MOVES
    • SANOFI-AVENTIS
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVE
    • VERTEX PHARMACEUTICALS
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVE

 

TABLE LIST

TABLE 1        GLOBAL ANTIFUNGAL DRUGS MARKET BY GEOGRAPHY 2017-2025 ($MILLION)

TABLE 2        GLOBAL ANTIFUNGAL DRUGS MARKET BY DRUG TYPES 2017-2025 ($ MILLION)

TABLE 3        INDICATION AND DOSES OF ECHINOCANDIN

TABLE 4        GLOBAL ECHINOCANDINS MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)

TABLE 5        DRUG USES OF TRIAZOLES

TABLE 6        GLOBAL AZOLES MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)

TABLE 7        GLOBAL POLYENES MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)

TABLE 8        PRICE OF ALLYLAMINE ANTIFUNGALS

TABLE 9        GLOBAL ALLYLAMINES MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)

TABLE 10      GLOBAL ANTIFUNGAL DRUGS MARKET BY THERAPEUTIC INDICATIONS MARKET 2017-2025 ($ MILLION)

TABLE 11      GLOBAL ASPERGILLOSIS MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)

TABLE 12      COMMON AFFECTED AREA – DERMATOPHYTES

TABLE 13      GLOBAL DERMATOPHYTOSIS MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)

TABLE 14      SYMPTOMS IN THE AFFECTED AREA CAUSED BY CANDIDIASIS

TABLE 15      GLOBAL CANDIDIASIS MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)

TABLE 16      GLOBAL OTHERS MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)

TABLE 17      GLOBAL ANTIFUNGAL DRUGS MARKET BY APPLICATIONS MARKET 2017-2025 ($ MILLION)

TABLE 18      PROS AND CONS OF TOPICAL MEDICATIONS

TABLE 19      BRANDS OF ANTIFUNGAL POWDERS AND THEIR FUNCTIONALITY

TABLE 20      BRANDS OF ANTIFUNGAL OINTMENTS AND THEIR FUNCTIONALITY

TABLE 21      ANTIFUNGAL PASTES AND ITS EFFECT

TABLE 22      COMMONLY USED ANTIFUNGAL DRUGS DOSAGE AND ITS EFFECTS

TABLE 23      GLOBAL ANTI-FUNGAL AGENT MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)

TABLE 24      NORTH AMERICA ANTI-FUNGAL MARKET BY REGION 2017-2025 ($ MILLION)

TABLE 25      EUROPE ANTI-FUNGAL AGENT MARKET 2017-2025 ($ MILLION)

TABLE 26      FINAL CONSUMPTION OF MEDICAL GOODS AND SERVICES BY HOUSEHOLD

TABLE 27      TOTAL BURDEN OF FUNGAL INFECTIONS IN SPAIN 2015

TABLE 28      ASIA PACIFIC ANTIFUNGAL DRUGS MARKET BY REGION 2017-2025 ($ MILLION)

TABLE 29      INDIA’S HEALTHCARE SECTOR INVESTMENT

TABLE 30      COMPANIES IN CHINA PRODUCING ANTIFUNGAL DRUGS

TABLE 31      TOTAL BURDEN OF FUNGAL INFECTIONS IN JAPAN

TABLE 32      REST OF THE WORLD ANTIFUNGAL DRUGS MARKET BY REGION 2017-2025 ($ MILLION)

 

FIGURES LIST

FIGURE 1      GLOBAL ANTIFUNGAL DRUGS MARKET 2017-2025 ($MILLION)

FIGURE 2      HEALTHCARE PROGRAMS INITIATED BY THE INDIAN GOVERNMENT

FIGURE 3      ALTERNATIVE MEDICINE IN US (IN MILLION US DOLLARS)

FIGURE 4      HEALTHCARE INDUSTRY IN THE WORLD IS RAPIDLY GROWING (%)

FIGURE 5      GLOBAL ECHINOCANDINS MARKET 2017-2025 ($ MILLION)

FIGURE 6      GLOBAL AZOLES MARKET 2017-2025 ($ MILLION)

FIGURE 7      GLOBAL POLYENES MARKET 2017-2025 ($ MILLION)

FIGURE 8      GLOBAL ALLYLAMINES MARKET 2017-2025 ($ MILLION)

FIGURE 9      GLOBAL OTHERS MARKET 2017-2025 ($ MILLION)

FIGURE 10   GLOBAL OTHERS MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)

FIGURE 11   GLOBAL ASPERGILLOSIS MARKET 2017-2025 ($ MILLION)

FIGURE 12   GLOBAL DERMATOPHYTOSIS MARKET 2017-2025 ($ MILLION)

FIGURE 13   GLOBAL CANDIDIASIS MARKET 2017-2025 ($ MILLION)

FIGURE 14   GLOBAL OTHERS MARKET 2017-2025 ($ MILLION)

FIGURE 15   TOPICAL ANTIFUNGAL DRUGS TYPES

FIGURE 16   GLOBAL TOPICAL ANTIFUNGAL DRUGS MARKET 2017-2025 ($ MILLION)

FIGURE 17   GLOBAL TOPICAL ANTIFUNGAL DRUGS MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)

FIGURE 18   GLOBAL ORAL DRUGS MARKET 2017-2025 ($ MILLION)

FIGURE 19   GLOBAL ORAL DRUGS MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)

FIGURE 20   PORTER’S FIVE FORCE MODEL IN ANTIFUNGAL DRUGS MARKET

FIGURE 21   HEALTHCARE INVESTMENT IN THE U.S. 2012-2015 ($ BILLION)

FIGURE 22   ANTI-FUNGAL DRUGS MARKET IN THE U.S.  2017-2025 ($ MILLION)

FIGURE 23   CANADA ANTIFUNGAL AGENT MARKET 2017-2025 ($ MILLION)

FIGURE 24   PHARMACEUTICAL SALES IN DIFFERENT COUNTRIES IN EUROPE 2014 ($ MILLION)

FIGURE 25   HEALTHCARE EXPENDITURE IN UK 2010-2015 (£ BILLION)

FIGURE 26   U.K. ANTIFUNGAL DRUGS MARKET 2017-2025 ($MILLION)

FIGURE 27   INVESTMENT MADE BY DIFFERENT DRUGS IN FRANCE 2015 (%)

FIGURE 28   FRANCE ANTI-FUNGAL DRUGS MARKET 2017-2025 ($ MILLION)

FIGURE 29   GERMANY ANTI-FUNGAL DRUGS MARKET 2017-2025 ($ MILLION)

FIGURE 30   SPAIN ANTI-FUNGAL DRUGS MARKET 2017-2025 ($ MILLION)

FIGURE 31   ITALY ANTI-FUNGAL DRUGS MARKET 2017-2025 ($ MILLION)

FIGURE 32   ROE ANTI-FUNGAL DRUGS MARKET 2017-2025 ($ MILLION)

FIGURE 33   PER CAPITA HEALTHCARE EXPENDITURE IN INDIA ($)

FIGURE 34   INDIA ANTIFUNGAL DRUGS MARKET 2017-2025 ($ MILLION)

FIGURE 35   CHINA ANTIFUNGAL DRUGS MARKET 2017-2025 ($ MILLION)

FIGURE 36   JAPAN ANTIFUNGAL DRUGS MARKET 2017-2025 ($ MILLION)

FIGURE 37   ROAPAC ANTIFUNGAL DRUGS MARKET 2017-2025 ($ MILLION)

FIGURE 38   LATIN AMERICA ANTIFUNGAL DRUGS MARKET 2017-2025 ($ MILLION)

FIGURE 39   VARIOUS SECTORS INVESTMENTS IN THE MENA REGION

FIGURE 40   MENA ANTIFUNGAL DRUGS MARKET 2017-2025 ($ MILLION)

FIGURE 41   AFRICA ANTIFUNGAL DRUGS MARKET 2017-2025 ($ MILLION)

FIGURE 42   GLOBAL ANTI-FUNGAL DRUGS MARKET SHARE ANALYSIS

  1. MARKET SEGMENTATION
    • BY DRUG TYPES
      • ECHINOCANDINS MARKET
      • AZOLES MARKET
      • POLYENES MARKET
      • ALLYLAMINES MARKET
      • OTHERS MARKET
    • BY THERAPEUTIC INDICATIONS
      • ASPERGILLOSIS MARKET
      • DERMATOPHYTOSIS MARKET
      • CANDIDIASIS MARKET
      • OTHERS MARKET
    • BY APPLICATIONS
      • TOPICAL ANTIFUNGAL AGENTS MARKET
      • ORAL DRUGS MARKET
  1. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA ANTIFUNGAL AGENTS MARKET 2017-2025 ($ MILLION)
      • UNITED STATES (U.S.) ANTIFUNGAL AGENTS MARKET
      • CANADA ANTIFUNGAL AGENTS MARKET
    • EUROPE ANTIFUNGAL AGENTS MARKET
      • UNITED KINGDOM (UK) ANTIFUNGAL AGENTS MARKET
      • FRANCE ANTIFUNGAL AGENTS MARKET
      • GERMANY ANTIFUNGAL AGENTS MARKET
      • SPAIN ANTIFUNGAL AGENTS MARKET
      • ITALY ANTIFUNGAL AGENTS MARKET
      • ROE ANTIFUNGAL AGENTS MARKET
    • ASIA PACIFIC ANTIFUNGAL AGENTS MARKET
      • INDIA ANTIFUNGAL AGENTS MARKET
      • CHINA ANTIFUNGAL AGENTS MARKET
      • JAPAN ANTIFUNGAL AGENTS MARKET
      • ROAPAC ANTIFUNGAL AGENTS MARKET
    • REST OF THE WORLD ANTIFUNGAL AGENTS MARKET
      • LATIN AMERICA ANTIFUNGAL AGENTS MARKET
      • MENA ANTIFUNGAL AGENTS MARKET
      • AFRICA ANTIFUNGAL AGENTS MARKET

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now